Cytodel
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
423 W 127th St, New York, New York, 1002...Website
www.cytodel.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Cytodel
CytoDel Inc. is a preclinical stage biopharmaceutical company specializing in the development of recombinant botulinum toxin (rBoT) derivatives designed to deliver therapeutics directly to the neuronal cytoplasm. Their patented technology platform enables the creation of antibody fusion proteins that target previously inaccessible areas within neurons. The company is focused on programs for biodefense and the treatment of nervous system disorders and chronic pain, including a Biobetter BoT with enhanced safety and efficacy. CytoDel aims to revolutionize intraneuronal drug delivery to improve therapeutic outcomes.Explore more
Cytodel Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytodel your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Cytodel has recently received funding, and reach out quickly before it becomes old news!
Check out if Cytodel is spiking on competitors!
Website visits: Recent activity has been detected on your website
Cytodel, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cytodel recently announced quarterly report
Funding: Get notified immidiatlly once Cytodel has new funding data
Click to see if Cytodel had a recent Job posting/layoffs
Product Launch: Get notified when Cytodel launches new products
Congratulate Masked Content for being promoted to Masked Content at Cytodel
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Cytodel
Compare insights from companies similar to Cytodel, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cytodel is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cytodel is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cytodel.
Cytodel financials insights
Gather financial insights about Cytodel, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$75K
Cytodel Tech Stack
A closer look at the technologies used by Cytodel
See more technologies
Cytodel News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Cytodel
Sign Up For FreeTo access detailed company insights
CytoDel Inc. is a preclinical stage biopharmaceutical company specializing in the development of recombinant botulinum toxin (rBoT) derivatives designed to deliver therapeutics directly to the neuronal cytoplasm. Their patented technology platform enables the creation of antibody fusion proteins that target previously inaccessible areas within neur... Read More
